These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
448 related articles for article (PubMed ID: 31109983)
1. A Guide to Understanding Antimicrobial Drug Dosing in Critically Ill Patients on Renal Replacement Therapy. Pistolesi V; Morabito S; Di Mario F; Regolisti G; Cantarelli C; Fiaccadori E Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31109983 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy. Pea F; Viale P; Pavan F; Furlanut M Clin Pharmacokinet; 2007; 46(12):997-1038. PubMed ID: 18027987 [TBL] [Abstract][Full Text] [Related]
3. Applying pharmacokinetic/pharmacodynamic principles for optimizing antimicrobial therapy during continuous renal replacement therapy. Honore PM; Jacobs R; De Waele E; Spapen HD Anaesthesiol Intensive Ther; 2017; 49(5):412-418. PubMed ID: 29171000 [TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetics of antibiotics in continuous renal replacement therapies (CRRT)]. Morabito S; Pistolesi V; Maggiore U; Fiaccadori E; Pierucci A G Ital Nefrol; 2012; 29(4):425-44. PubMed ID: 22843155 [TBL] [Abstract][Full Text] [Related]
5. Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis. Heintz BH; Matzke GR; Dager WE Pharmacotherapy; 2009 May; 29(5):562-77. PubMed ID: 19397464 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and antimicrobial dosing adjustment in critically ill patients during continuous renal replacement therapy. Kuang D; Verbine A; Ronco C Clin Nephrol; 2007 May; 67(5):267-84. PubMed ID: 17542336 [TBL] [Abstract][Full Text] [Related]
7. Drug dosing in continuous renal replacement therapy: general rules. Schetz M Curr Opin Crit Care; 2007 Dec; 13(6):645-51. PubMed ID: 17975384 [TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetic principles and drug-dosing adjustments during continuous renal replacement therapies (CRRT)]. Morabito S; Guzzo I; Vitaliano E; Muzi L; Solazzo A; Pistolesi V; Pierucci A G Ital Nefrol; 2006; 23 Suppl 36():S127-38. PubMed ID: 17068740 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of Commonly Used Medications in Children Receiving Continuous Renal Replacement Therapy: A Systematic Review of Current Literature. Dubinsky S; Watt K; Saleeb S; Ahmed B; Carter C; Yeung CHT; Edginton A Clin Pharmacokinet; 2022 Feb; 61(2):189-229. PubMed ID: 34846703 [TBL] [Abstract][Full Text] [Related]
10. The influence of acute kidney injury on antimicrobial dosing in critically ill patients: are dose reductions always necessary? Blot S; Lipman J; Roberts DM; Roberts JA Diagn Microbiol Infect Dis; 2014 May; 79(1):77-84. PubMed ID: 24602849 [TBL] [Abstract][Full Text] [Related]
11. Machines that help machines to help patients: optimising antimicrobial dosing in patients receiving extracorporeal membrane oxygenation and renal replacement therapy using dosing software. Roberts JA; Bellomo R; Cotta MO; Koch BCP; Lyster H; Ostermann M; Roger C; Shekar K; Watt K; Abdul-Aziz MH Intensive Care Med; 2022 Oct; 48(10):1338-1351. PubMed ID: 35997793 [TBL] [Abstract][Full Text] [Related]
12. Effects of continuous renal replacement therapy on linezolid pharmacokinetic/pharmacodynamics: a systematic review. Villa G; Di Maggio P; De Gaudio AR; Novelli A; Antoniotti R; Fiaccadori E; Adembri C Crit Care; 2016 Nov; 20(1):374. PubMed ID: 27863531 [TBL] [Abstract][Full Text] [Related]
14. How can we ensure effective antibiotic dosing in critically ill patients receiving different types of renal replacement therapy? Jamal JA; Mueller BA; Choi GY; Lipman J; Roberts JA Diagn Microbiol Infect Dis; 2015 May; 82(1):92-103. PubMed ID: 25698632 [TBL] [Abstract][Full Text] [Related]
15. Antimicrobial Dose Reduction in Continuous Renal Replacement Therapy: Myth or Real Need? A Practical Approach for Guiding Dose Optimization of Novel Antibiotics. Gatti M; Pea F Clin Pharmacokinet; 2021 Oct; 60(10):1271-1289. PubMed ID: 34125420 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of Commonly Used Antimicrobials in Critically Ill Adults During Extracorporeal Membrane Oxygenation: A Systematic Review. Duceppe MA; Kanji S; Do AT; Ruo N; Cavayas YA; Albert M; Robert-Halabi M; Zavalkoff S; Dupont P; Samoukovic G; Williamson DR Drugs; 2021 Jul; 81(11):1307-1329. PubMed ID: 34224115 [TBL] [Abstract][Full Text] [Related]
17. The effect of pathophysiology on pharmacokinetics in the critically ill patient--concepts appraised by the example of antimicrobial agents. Blot SI; Pea F; Lipman J Adv Drug Deliv Rev; 2014 Nov; 77():3-11. PubMed ID: 25038549 [TBL] [Abstract][Full Text] [Related]
18. Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability. Pea F; Viale P; Furlanut M Clin Pharmacokinet; 2005; 44(10):1009-34. PubMed ID: 16176116 [TBL] [Abstract][Full Text] [Related]
19. [Drugs dosing in intensive care unit during continuous renal replacement therapy]. Bourquin V; Ponte B; Saudan P; Martin PY Nephrol Ther; 2009 Nov; 5(6):533-41. PubMed ID: 19369134 [TBL] [Abstract][Full Text] [Related]
20. A primer on continuous renal replacement therapy for critically ill patients. Joy MS; Matzke GR; Armstrong DK; Marx MA; Zarowitz BJ Ann Pharmacother; 1998 Mar; 32(3):362-75. PubMed ID: 9533067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]